An Updated Analysis of the Survival Endpoints of ASCENDE-RT-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An Updated Analysis of the Survival Endpoints of ASCENDE-RT

Published:2023-04 Issue:5 Volume:115 Page:1061-1070
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Oh Justin,Tyldesley Scott,Pai Howard,McKenzie Michael,Halperin Ross,Duncan Graeme,Morton Gerard,Keyes Mira,Hamm Jeremy,Morris W. James

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference38 articles.

1. Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer

2. Prostate cancer, version 2.2019, NCCN Clinical Practice Guidelines in Oncology;Mohler;J Natl Compr Canc Netw,2019

3. Prostate-specific antigen at 4 to 5 years after low-dose-rate prostate brachytherapy is a strong predictor of disease-free survival;Lo;Int J Radiat Oncol Biol Phys,2014

4. A biochemical definition of cure after brachytherapy for prostate cancer;Crook;Radiother Oncol,2020

5. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer;Al-Mamgani;Int J Radiat Oncol Biol Phys,2008

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single–dose high-dose-rate brachytherapy versus two and three fractions for locally advanced prostate cancer;Radiotherapy and Oncology;2024-10

2. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent;European Urology;2024-08

3. Tolérance à court et moyen terme d’une radiothérapie prostatique hypofractionnée selon la technique du boost intégré;Cancer/Radiothérapie;2024-08

4. The expanding role of radiation oncology across the prostate cancer continuum;Abdominal Radiology;2024-06-20

5. Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost;Strahlentherapie und Onkologie;2024-06-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3